How much is Ajax Therapeutics worth in 2026?

Ajax Therapeutics has a current valuation of $192.5M based on their Later Stage VC round and secondary market data.

How much funding has Ajax Therapeutics raised?

Ajax Therapeutics has raised $143.0M in total funding across 1 funding rounds.

Ajax Therapeutics

Drug DiscoveryWebsite

Ajax Therapeutics valuation and funding history | Last updated: May 13, 2024 | 1 funding rounds

Current Valuation

$192.5M

As of May 13, 2024

Total Funding Raised

$143.0M

Across 1 round

Last Round

Later Stage VC

$95.0M

Last Funding

May 2024

Funding date

Capital Efficiency

1.35x

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
May 13, 2024	Later Stage VC (Series C)	$95.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Ajax Therapeutics is currently valued at $192.5M as of May 13, 2024. The company has raised a total of $143.0M in funding across 1 funding round.

Capital Efficiency

With a capital efficiency ratio of 1.35x, Ajax Therapeutics has achieved a valuation that is 1.35 times the total capital raised.

Track Ajax Therapeutics Valuation Updates

Get notified when Ajax Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Ajax Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Ajax Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Ajax Therapeutics Worth in 2026?

Ajax Therapeutics is a leading private company in the Drug Discovery sector. Track Ajax Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Ajax Therapeutics Valuation is Determined

Private company valuations like Ajax Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.